Bank of New York Mellon’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-49,377
| Closed | -$188K | – | 4259 |
|
|
2019
Q3 | $188K | Hold |
49,377
| – | – | ﹤0.01% | 3909 |
|
|
2019
Q2 | $328K | Buy |
49,377
+21,971
| +80% | +$146K | ﹤0.01% | 3778 |
|
|
2019
Q1 | $98K | Sell |
27,406
-1,182
| -4% | -$4.23K | ﹤0.01% | 3999 |
|
|
2018
Q4 | $113K | Buy |
28,588
+2,914
| +11% | +$11.5K | ﹤0.01% | 3938 |
|
|
2018
Q3 | $508K | Buy |
25,674
+7,268
| +39% | +$144K | ﹤0.01% | 3640 |
|
|
2018
Q2 | $584K | Buy |
18,406
+7,231
| +65% | +$229K | ﹤0.01% | 3559 |
|
|
2018
Q1 | $413K | Buy |
11,175
+3,692
| +49% | +$136K | ﹤0.01% | 3660 |
|
|
2017
Q4 | $592K | Buy |
+7,483
| New | +$592K | ﹤0.01% | 3523 |
|